Design World

  • Home
  • Technologies
    • ELECTRONICS • ELECTRICAL
    • Fastening • joining
    • FLUID POWER
    • LINEAR MOTION
    • MOTION CONTROL
    • SENSORS
    • TEST & MEASUREMENT
    • Factory automation
    • Warehouse automation
    • DIGITAL TRANSFORMATION
  • Learn
    • Tech Toolboxes
    • Learning center
    • eBooks • Tech Tips
    • Podcasts
    • Videos
    • Webinars • general engineering
    • Webinars • Automated warehousing
    • Voices
  • LEAP Awards
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Design Guides
  • Resources
    • Subscribe
    • 3D Cad Models
      • PARTsolutions
      • TraceParts
    • Digital Issues
      • Design World
      • EE World
    • Educational Assets
    • Engineering diversity
    • Trends
  • Supplier Listings
  • Advertise
  • Subscribe

Ex-DEA Official Call Lawmakers’ Attempt To Fight Opioid Epidemic ‘A Farce’

By Meagan Parrish | November 2, 2016

Don’t be fooled by American lawmakers’ recent legislative efforts to curb the opioid epidemic. At least that’s the message from a former top Drug Enforcement Agency official recently interviewed by The Guardian, who called those measures “a farce,” and said that Congress is still too wedded to pharmaceutical companies to push for meaningful regulations.

Joseph Rannazzisi was director of the DEA’s office of diversion control for a decade and left the post last year. Rannazzisi said he saw how pharma lobbyists spent millions influencing lawmakers and helping craft weak legislation that appears to fight opioid abuse, but lacks regulatory teeth.

He also said that many lawmakers touting their efforts to pass opioid-related legislation are only selling hype.

“These congressmen and senators who are using this because they are up for re-election, it’s a sham,” Rannazzisi said. “The congressmen and senators who are championing this fight, the ones who really believe in what they’re doing, their voices are drowned out because the industry has too much influence.”

For example, Rannazzisi said that in April, Congress passed a law that reduced the DEA’s power to suspend licenses of distributors and pharmacists accused of dispensing excessive opioid prescriptions. Called The Ensuring Patient Access and Effective Drug Enforcement Act, the law requires that the DEA warn drug distributors if they aren’t in compliance with regulations and gives them time to shape up. In effect, Rannazzisi said this provision gives them a “free pass.”

While proponents of the bill said it was aimed at making sure the DEA doesn’t over-extend its powers, Rannazzisi maintains that the agency only wants to go after the most serious offenders.

Rannazzisi also accused industry-funded pain groups such as the Pain Care Forum of being too influential in lobbying Congress.

Senator Ron Wyden (D-Ore.) echoed Rannazzisi’s claims, saying that even the government-run Interagency Pain Research Coordinating Committee (IPRCC) has been corrupted by pharma companies who influence the group’s panel of experts.

IPRCC was instrumental in crafting the Centers For Disease Control and Prevention’s “Guideline For Prescribing Opioids For Chronic Pain” earlier this year, which Wyden said skewed the panel to “weaken” the recommendations.

And even though a Congress launched a committee to investigate how the CDC arrived at its guidelines, Rannazzisi said the appearance of pressure on the industry influence permeating Capitol Hill wasn’t what it seemed.

“The industry got Congress to put pressure on the CDC over their prescribing guidelines. That was just a farce,” he said. 

Ultimately the committee found no evidence of wrongdoing on the part of the CDC. 

The CDC guidelines released this year encourage primary care doctors to try alternate therapies before prescribing narcotics and to prescribe them in smaller quantities and doses. Yet, doctors are under no obligation to adopt the guidelines into their prescribing practices.

According to the CDC, about 40 Americans are dying every day from overdoses involving painkillers and 2 million people abuse the drugs each year.

Despite the ongoing wrangling among lawmakers about how to handle the epidemic, prescribing rates among some groups and in some states have fallen sharply in the last few years.

Yet, in many states they’ve remained stubbornly high and according to one recent report, the epidemic continues to outpace expanding treatment options.  

You Might Also Like


Filed Under: Industry regulations + certifications

 

LEARNING CENTER

Design World Learning Center
“dw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest info on technologies, tools and strategies for Design Engineering Professionals.
Motor University

Design World Digital Edition

cover

Browse the most current issue of Design World and back issues in an easy to use high quality format. Clip, share and download with the leading design engineering magazine today.

EDABoard the Forum for Electronics

Top global problem solving EE forum covering Microcontrollers, DSP, Networking, Analog and Digital Design, RF, Power Electronics, PCB Routing and much more

EDABoard: Forum for electronics

Sponsored Content

  • Widening the scope for machine tool designers with FORTiS™ enclosed encoder
  • Sustainability, Innovation and Safety, Central to Our Approach
  • Why off-highway is the sweet spot for AC electrification technology
  • Looking to 2025: Past Success Guides Future Achievements
  • North American Companies Seek Stronger Ties with Italian OEMs
  • Adapt and Evolve
View More >>
Engineering Exchange

The Engineering Exchange is a global educational networking community for engineers.

Connect, share, and learn today »

Design World
  • About us
  • Contact
  • Manage your Design World Subscription
  • Subscribe
  • Design World Digital Network
  • Control Engineering
  • Consulting-Specifying Engineer
  • Plant Engineering
  • Engineering White Papers
  • Leap Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Design World

  • Home
  • Technologies
    • ELECTRONICS • ELECTRICAL
    • Fastening • joining
    • FLUID POWER
    • LINEAR MOTION
    • MOTION CONTROL
    • SENSORS
    • TEST & MEASUREMENT
    • Factory automation
    • Warehouse automation
    • DIGITAL TRANSFORMATION
  • Learn
    • Tech Toolboxes
    • Learning center
    • eBooks • Tech Tips
    • Podcasts
    • Videos
    • Webinars • general engineering
    • Webinars • Automated warehousing
    • Voices
  • LEAP Awards
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Design Guides
  • Resources
    • Subscribe
    • 3D Cad Models
      • PARTsolutions
      • TraceParts
    • Digital Issues
      • Design World
      • EE World
    • Educational Assets
    • Engineering diversity
    • Trends
  • Supplier Listings
  • Advertise
  • Subscribe
We use cookies to personalize content and ads, to provide social media features, and to analyze our traffic. We share information about your use of our site with our social media, advertising, and analytics partners who may combine it with other information you’ve provided to them or that they’ve collected from your use of their services. You consent to our cookies if you continue to use this website.